Synapse - Works

Results (3382)

Initial analytic validation of automated bone scan measures for treatment response assessment in patients with metastatic castration-resistant prostate cancer (CRPC)

Meeting Abstract

Chu, G. H.; Brown, M. S.; Kim, H. J.; Auerbach, M.; Poon, C.; Ramakrishna, B.; Vidovic, A.; Gjertson, D. W.; Morris, M. J.; Larson, S. M.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis

Meeting Abstract

Callahan, M. K.; Yang, A.; Tandon, S.; Xu, Y.; Subudhi, S. K.; Roman, R. A.; Heine, A. I.; Pogoriler, E.; Kuk, D.; Panageas, K.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A first-in-human phase I study of MORAb-004 (MOR4), a humanized monoclonal antibody recognizing TEM-1 (endosialin), in patients with solid tumors

Meeting Abstract

Carvajal, R. D.; Gounder, M. M.; Coughlin, C. M.; Fishel, J.; Heyburn, J.; O'Shannessy, D.; Grasso, L.; Schweizer, C.; Parno, J.; Old, L. J.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Safety, pharmacokinetics (PK), pharmacodynamics (PD), and clinical activity of the oral AKT inhibitor GSK2141795 (GSK795) in a phase I first-in-human study

Meeting Abstract

Burris, H. A.; Siu, L. L.; Infante, J. R.; Wheler, J. J.; Kurkjian, C.; Opalinska, J.; Smith, D. A.; Antal, J. M.; Gauvin, J. L.; Gonzalez, T.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC)

Meeting Abstract

Camidge, D. R.; Bang, Y.; Kwak, E. L.; Shaw, A. T.; Iafrate, A. J.; Maki, R. G.; Solomon, B. J.; Ou, S. I.; Salgia, R.; Wilner, K. D.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Synergistic potentiation of antitumor immunity with light-activated drug therapy and anti-CTLA4 antibody treatment

Meeting Abstract

Bromley, E.; Waitz, R.; Wang, S.; Allison, J. P.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Automated tumor detection on bone scans for treatment response assessment

Meeting Abstract

Brown, M. S.; Chu, G. H.; Kim, H. J.; Auerbach, M.; Poon, C.; Vidovic, A.; Ramakrishna, B.; Gjertson, D. W.; Morris, M. J.; Larson, S. M.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors

Meeting Abstract

Beryozkina, A.; Nichols, G. L.; Reckner, M.; Vassilev, L. T.; Rueger, R.; Jukofsky, L.; Middleton, S.; Andreeff, M.; Padmanabhan, S.; Strair, R.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Treatment (Tx) guidelines for skin and mucosal events in patients with solid tumors (pts) receiving TH-302, a tumor selective, hypoxia-activated prodrug

Meeting Abstract

Borad, M. J.; Boyer, N.; Curd, J. G.; Sunkara, U. K.; Awerkamp, K.; Lacouture, M. E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Coordination of care: Lessons learned from a pilot study in head and neck cancer

Meeting Abstract

Baxi, S. S.; Monether, C.; Wong, R. J.; Miransky, J.; Pfister, D. G.; Kelvin, J. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save